Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis

Cancer and Metastasis Reviews · Published 2025-02-21 · Journal article · DOI 10.1007/s10555-025-10246-6 · Cited by 25 (Crossref)

Free full text

Authors (8)

Aiarpi Ezdoglian, Michel Tsang-A-Sjoe, Fatemeh Khodadust, George Burchell, Gerrit Jansen, Tanja de Gruijl, Mariette Labots, Conny J. van der Laken

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume

44

Issue

1

Year

2025

Citation

Ezdoglian, A., Tsang-A-Sjoe, M., Khodadust, F., et al. (2025). Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-025-10246-6

Related articles

• Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score · Cancer Immunology, Immunotherapy · 2023 · Cites or is cited by this article
• Circulating leukocyte–platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents · Cancer Immunology, Immunotherapy · 2021 · Cites or is cited by this article
• Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab · Cancer Immunology, Immunotherapy · 2021 · Cites or is cited by this article
• The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study · Cancer Immunology, Immunotherapy · 2023 · Cites or is cited by this article
• Using ultrasound and microbubble to enhance the effects of conventional cancer therapies in clinical settings · Cancer and Metastasis Reviews · 2025 · Same journal
• CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting · Cancer and Metastasis Reviews · 2025 · Same journal
• Neuronal mimicry in tumors: lessons from neuroscience to tackle cancer · Cancer and Metastasis Reviews · 2025 · Same journal
• Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy · Cancer and Metastasis Reviews · 2025 · Same journal
• Epigenetic drugs in cancer therapy · Cancer and Metastasis Reviews · 2025 · Same journal
• Mitochondrial alterations and signatures in hepatocellular carcinoma · Cancer and Metastasis Reviews · 2025 · Same journal

Metrics

Citations (Crossref)

25